Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hakeem

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cureus|November 10, 2021
Isolated Polycystic Liver Disease: A Rare Genetic DisorderHabib Y Aldabbab, Moayad A Hakeem, Fatimah M Alanazi, et al.
Cureus|January 26, 2024
Retraction: Isolated Polycystic Liver Disease: A Rare Genetic DisorderHabib Y Aldabbab, Moayad A Hakeem, Fatimah M Alanazi, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonistsMark A Matulenko, Ahmed A Hakeem, Teodozyi Kolasa, et al.
Bioorganic & Medicinal Chemistry|May 18, 2005
Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonistsXueqing Wang, Pramila A Bhatia, Jerome F Daanen, et al.
Nature Communications|March 6, 2015
Metal organic framework-mediated synthesis of highly active and stable Fischer-Tropsch catalystsVera P Santos, Tim A Wezendonk, Juan José Delgado Jaén, et al.
Journal of Medicinal Chemistry|August 18, 2006
1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunctionTeodozyj Kolasa, Mark A Matulenko, Ahmed A Hakeem, et al.
Cell|February 26, 2021
In vivo CD8<sup>+</sup> T cell CRISPR screening reveals control by Fli1 in infection and cancerZeyu Chen, Eri Arai, Omar Khan, et al.
Journal of Medicinal Chemistry|December 8, 2006
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunctionMeena V Patel, Teodozyj Kolasa, Kathleen Mortell, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cureus|November 10, 2021
Isolated Polycystic Liver Disease: A Rare Genetic DisorderHabib Y Aldabbab, Moayad A Hakeem, Fatimah M Alanazi, et al.
Cureus|January 26, 2024
Retraction: Isolated Polycystic Liver Disease: A Rare Genetic DisorderHabib Y Aldabbab, Moayad A Hakeem, Fatimah M Alanazi, et al.
Bioorganic & Medicinal Chemistry|June 10, 2004
Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonistsMark A Matulenko, Ahmed A Hakeem, Teodozyi Kolasa, et al.
Bioorganic & Medicinal Chemistry|May 18, 2005
Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonistsXueqing Wang, Pramila A Bhatia, Jerome F Daanen, et al.
Nature Communications|March 6, 2015
Metal organic framework-mediated synthesis of highly active and stable Fischer-Tropsch catalystsVera P Santos, Tim A Wezendonk, Juan José Delgado Jaén, et al.
Journal of Medicinal Chemistry|August 18, 2006
1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunctionTeodozyj Kolasa, Mark A Matulenko, Ahmed A Hakeem, et al.
Cell|February 26, 2021
In vivo CD8<sup>+</sup> T cell CRISPR screening reveals control by Fli1 in infection and cancerZeyu Chen, Eri Arai, Omar Khan, et al.
Journal of Medicinal Chemistry|December 8, 2006
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunctionMeena V Patel, Teodozyj Kolasa, Kathleen Mortell, et al.
Pageof 6